Clioquinol (5-chloro-7-iodo-8-quinolinol) is a copper ionophore that was used primarily during the 1950–1970s as an oral antimicrobial agent. It has been established that clioquinol displays toxicity towards malignant cells, inducing caspase-dependent apoptosis. In the present study we therefore investigated the effect of clioquinol on the XIAP [X-linked IAP (inhibitor of apoptosis protein)], as one of its primary functions is to hinder caspase activity and suppress apoptotic cell death. Clioquinol treatment caused cytoplasmic XIAP to rapidly relocate to the nucleus in multiple human transformed (hyperplasic and carcinoma) prostate lines. Clioquinol also caused the cytoplasmic clearance of other IAP family members (cIAP1 and cIAP2). Copper, and no other relevant bivalent metal (e.g. zinc or iron), was exclusively required for clioquinol to elicit an effect on XIAP. We further demonstrated that clioquinol selectively targets and rapidly destroys transformed prostate lines without harming primary prostate epithelial cells. The toxicity of clioquinol was copper-dependent, positively correlated with the level of extracellular copper and could be abrogated by using the copper chelator TTM (tetrathiomolybdate). Clioquinol forced the profound accumulation of intracellular copper with ensuing toxicity influenced by key regulators of cellular copper homoeostasis. Taken together, our results provide significant insight into clioquinol toxicity and reveal an exciting therapeutic approach for the treatment of prostate cancer.
Skip Nav Destination
Article navigation
June 2011
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
May 13 2011
Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer
Michael A. Cater;
Michael A. Cater
1
1Research Division, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, VIC 3002, Australia
1To whom correspondence should be addressed to (email: michael.cater@petermac.org).
Search for other works by this author on:
Ygal Haupt
Ygal Haupt
1Research Division, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, VIC 3002, Australia
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 19 2011
Revision Received:
March 16 2011
Accepted:
March 23 2011
Accepted Manuscript online:
March 23 2011
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2011 Biochemical Society
2011
Biochem J (2011) 436 (2): 481–491.
Article history
Received:
January 19 2011
Revision Received:
March 16 2011
Accepted:
March 23 2011
Accepted Manuscript online:
March 23 2011
Connected Content
Citation
Michael A. Cater, Ygal Haupt; Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J 1 June 2011; 436 (2): 481–491. doi: https://doi.org/10.1042/BJ20110123
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.